33.44 - 34.57
31.40 - 61.90
7.61M / 5.87M (Avg.)
-152.73 | -0.22
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
7.63%
Revenue growth at 75-90% of CFLT's 8.60%. Bill Ackman would push for innovation or market expansion to catch up.
6.06%
Gross profit growth under 50% of CFLT's 13.09%. Michael Burry would be concerned about a severe competitive disadvantage.
4.87%
EBIT growth below 50% of CFLT's 10.05%. Michael Burry would suspect deeper competitive or cost structure issues.
4.87%
Operating income growth under 50% of CFLT's 10.05%. Michael Burry would be concerned about deeper cost or sales issues.
9.45%
Net income growth under 50% of CFLT's 32.20%. Michael Burry would suspect the firm is falling well behind a key competitor.
7.14%
EPS growth under 50% of CFLT's 32.69%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
7.14%
Diluted EPS growth under 50% of CFLT's 32.69%. Michael Burry would worry about an eroding competitive position or excessive dilution.
0.88%
Share reduction more than 1.5x CFLT's 2.04%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
0.88%
Diluted share reduction more than 1.5x CFLT's 2.04%. David Dodd would validate if the company is aggressively retiring shares or limiting option exercises.
No Data
No Data available this quarter, please select a different quarter.
24.20%
OCF growth under 50% of CFLT's 62.63%. Michael Burry might suspect questionable revenue recognition or rising costs.
27.27%
FCF growth under 50% of CFLT's 57.53%. Michael Burry would suspect weaker operating efficiencies or heavier capex burdens.
-26.87%
Negative 10Y revenue/share CAGR while CFLT stands at 164.67%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-26.87%
Negative 5Y CAGR while CFLT stands at 164.67%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-26.87%
Negative 3Y CAGR while CFLT stands at 164.67%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
60.31%
Positive long-term OCF/share growth while CFLT is negative. John Neff would see a structural advantage in sustained cash generation.
60.31%
Positive OCF/share growth while CFLT is negative. John Neff might see a comparative advantage in operational cash viability.
60.31%
Positive 3Y OCF/share CAGR while CFLT is negative. John Neff might see a big short-term edge in operational efficiency.
1.38%
Positive 10Y CAGR while CFLT is negative. John Neff might see a substantial advantage in bottom-line trajectory.
1.38%
Positive 5Y CAGR while CFLT is negative. John Neff might view this as a strong mid-term relative advantage.
1.38%
Positive short-term CAGR while CFLT is negative. John Neff would see a clear advantage in near-term profit trajectory.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-8.79%
Firm’s AR is declining while CFLT shows 11.23%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-6.99%
Inventory is declining while CFLT stands at 6.38%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-1.03%
Negative asset growth while CFLT invests at 1.52%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-1.83%
We have a declining book value while CFLT shows 0.17%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
-4.00%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
2.10%
R&D growth drastically higher vs. CFLT's 0.93%. Michael Burry fears near-term margin erosion unless breakthroughs are imminent.
1.53%
SG&A growth well above CFLT's 0.08%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.